Follow-up After Surgery for Testicular Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorErasmus Medical Center
About this trial
The currently developed implementation study aims to evaluate if a patient-led home-based follow-up approach is successful, improves quality of life, reduces anxiety and lessens fear of cancer recurrence during the years after treatment of certain types of testicular cancer.
Eligibility criteria
Qualifiers
Age ≥ 18 years.
No lymphadenopathy or metastases on the postoperative scan.
Three consecutive blood drawings with normal tumour markers.
Patients undergoing lymph node dissection as a second curative operation after an orchiectomy, can also be included in case that the postoperative scan shows no residual disease or metastases.
Disqualifiers
Patients with aberrant levels of LDH preoperatively (LDH >248 U/L).
Patients enrolled in other studies that require strict adherence to any specific follow-up practice with regular imaging - yearly or more frequent - of the abdomen and/or thorax
Patients with comorbidity or other malignancy that requires imaging of the abdomen and/or thorax every year or more frequent
Inability to complete the questionnaires due to illiteracy and/or insufficient proficiency of the Dutch language
Trial design
Treatments tested in this trial
- Not listed
Trial groups
145 Participants
are grouped into 4 trial groupsLocations
1Erasmus Medical Center3015GD, RotterdamSouth Holland, Netherlands
Sponsors and collaborators
Erasmus Medical Center
Lead sponsor
Source ClinicalTrials.gov